Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by PACK Private Wealth LLC

UNH CUSIP 91324P102 Manager CIK 0001907212

Reported 6,482 shares, unchanged from the prior quarter.

Reported value 3.5%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 2.02% This manager · Q1 2025
Shares 6,482 Quarter-end amount reported
Reported value $3,394,948 Fair value at quarter end
Consecutive quarters held 14 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 5278000
2022-03-31 5360000
2022-06-30 4883000
2022-09-30 4794000
2022-12-31 5032469
2023-03-31 4485824
2023-06-30 4562235
2023-09-30 4884298
2023-12-31 3933784
2024-03-31 3696398
2024-06-30 3810283
2024-09-30 3789896
2024-12-31 3278985
2025-03-31 3394948
2025-06-30 2985241
2025-09-30 3304176
2025-12-31 3157832
2026-03-31 2588464
2026-06-30 3975917

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by PACK Private Wealth LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Unchanged 9,566 0 (0.0%) 1.65% $3,975,917 2026-08-12
Q1 2026 Unchanged 9,566 0 (0.0%) 1.19% $2,588,464 2026-05-15
Q4 2025 Reduced 9,566 -3 (0.0%) 1.44% $3,157,832 2026-02-17
Q3 2025 Unchanged 9,569 0 (0.0%) 1.56% $3,304,176 2025-11-06
Q2 2025 Added 9,569 +3,087 (47.6%) 1.58% $2,985,241 2025-08-13
Q1 2025 Unchanged 6,482 0 (0.0%) 2.02% $3,394,948 2025-05-13
Q4 2024 Unchanged 6,482 0 (0.0%) 1.93% $3,278,985 2025-02-03
Q3 2024 Reduced 6,482 -1,000 (-13.4%) 2.15% $3,789,896 2024-10-28
Q2 2024 Added 7,482 +10 (0.1%) 2.37% $3,810,283 2024-08-02
Q1 2024 Unchanged 7,472 0 (0.0%) 2.32% $3,696,398 2024-05-03
Q4 2023 Reduced 7,472 -2,020 (-21.3%) 2.65% $3,933,784 2024-02-06
Q3 2023 Unchanged 9,492 0 (0.0%) 3.65% $4,884,298 2023-11-01
Q2 2023 Unchanged 9,492 0 (0.0%) 3.41% $4,562,235 2023-07-14
Q1 2023 Unchanged 9,492 0 (0.0%) 3.56% $4,485,824 2023-04-18
Q4 2022 Unchanged 9,492 0 (0.0%) 4.32% $5,032,469 2023-01-30
Q3 2022 Reduced 9,492 -14 (-0.1%) 4.51% $4,794,000 2022-11-09
Q2 2022 Reduced 9,506 -1,005 (-9.6%) 4.46% $4,883,000 2022-08-12
Q1 2022 Unchanged 10,511 0 (0.0%) 4.42% $5,360,000 2022-05-16
Q4 2021 New 10,511 +10,511 (0.0%) 4.19% $5,278,000 2022-02-15

Who else reported the position

3836 managers reported UNITEDHEALTH GROUP INC for Q1 2025.

Managers reporting UNITEDHEALTH GROUP INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 90,729,585 +5,583,343 0.86% $47,519,620,144 48 qtrs
BlackRock Inc Added 74,290,219 +2,275,323 0.82% $38,909,501,589 3 qtrs
STATE STREET CORPORATION Reduced 45,338,514 -254,389 0.98% $23,746,046,708 48 qtrs
JPMorgan Chase & Co Added 26,293,837 +1,861,002 1.01% $13,771,398,071 48 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 25,847,940 +2,486,839 2.6% $13,537,858,577 48 qtrs
FMR LLC Reduced 24,217,466 -5,903,163 0.81% $12,683,897,629 48 qtrs
Capital World Investors Added 22,779,755 +1,264,026 1.93% $11,930,227,778 48 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 21,393,161 -8,593 1.38% $11,204,669,000 48 qtrs
MORGAN STANLEY Reduced 21,364,718 -31,480 0.8% $11,189,772,617 48 qtrs
Capital Research Global Investors Added 20,827,122 +2,860,632 2.37% $10,908,147,878 48 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 13, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
6,482

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.